Zebra Technologies (NASDAQ:ZBRA) Releases Q2 Earnings Guidance

Zebra Technologies (NASDAQ:ZBRA) issued an update on its second quarter earnings guidance on Tuesday morning. The company provided EPS guidance of $2.60-$2.90 for the period, compared to the consensus EPS estimate of $2.56. The company issued revenue guidance of $1.153-$1.202 billion, compared to the consensus revenue estimate of $1.14 billion. Zebra Technologies also updated its FY 2024 guidance to 11.250-12.250 EPS.

Zebra Technologies Stock Up 6.2 %

Shares of Zebra Technologies stock opened at $318.59 on Tuesday. Zebra Technologies has a 1-year low of $194.59 and a 1-year high of $320.55. The company has a market capitalization of $16.37 billion, a PE ratio of 52.54 and a beta of 1.79. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.05 and a quick ratio of 0.54. The business has a 50-day moving average of $286.87 and a 200-day moving average of $255.96.

Zebra Technologies (NASDAQ:ZBRA) last issued its quarterly earnings data on Tuesday, April 30th. The industrial products company reported $2.84 earnings per share for the quarter, beating analysts’ consensus estimates of $2.14 by $0.70. Zebra Technologies had a return on equity of 15.30% and a net margin of 6.46%. The firm had revenue of $1.18 billion during the quarter, compared to analyst estimates of $1.15 billion. During the same quarter last year, the firm earned $3.59 EPS. Zebra Technologies’s quarterly revenue was down 16.4% on a year-over-year basis. As a group, equities analysts forecast that Zebra Technologies will post 9.76 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages have recently commented on ZBRA. Wolfe Research raised Zebra Technologies from a peer perform rating to an outperform rating and set a $337.00 target price for the company in a research report on Monday, April 8th. StockNews.com lowered shares of Zebra Technologies from a hold rating to a sell rating in a research report on Friday, February 16th. Truist Financial started coverage on shares of Zebra Technologies in a research report on Thursday, March 14th. They set a hold rating and a $300.00 price objective on the stock. Finally, Barclays began coverage on shares of Zebra Technologies in a report on Tuesday, April 2nd. They set an equal weight rating and a $292.00 price target on the stock. Three equities research analysts have rated the stock with a sell rating, three have assigned a hold rating and seven have given a buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of Hold and an average target price of $278.64.

Insiders Place Their Bets

In other news, CAO Colleen M. O’sullivan sold 135 shares of the stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $279.36, for a total transaction of $37,713.60. Following the transaction, the chief accounting officer now owns 5,543 shares of the company’s stock, valued at approximately $1,548,492.48. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 1.04% of the company’s stock.

About Zebra Technologies

Zebra Technologies Corporation, together with its subsidiaries, provides enterprise asset intelligence solutions in the automatic identification and data capture solutions industry worldwide. It operates in two segments, Asset Intelligence & Tracking, and Enterprise Visibility & Mobility. The company designs, manufactures, and sells printers that produce labels, wristbands, tickets, receipts, and plastic cards; dye-sublimination thermal card printers that produce images, which are used for personal identification, access control, and financial transactions; radio frequency identification device (RFID) printers that encode data into passive RFID transponders; accessories and options for printers, including carrying cases, vehicle mounts, and battery chargers; stock and customized thermal labels, receipts, ribbons, plastic cards, and RFID tags for printers; and temperature-monitoring labels primarily used in vaccine distribution.